Ian Karp | Vice President, Investor and Public Relations |
Michael Kauffman | Chief Executive Officer |
Mike Mason | Chief Financial Officer |
Perry Monaco | Senior Vice President, Sales |
Maury Raycroft | Jefferies |
Michael Ulz | Baird |
Ed White | H.C. Wainwright |
Jonathan Chang | Leerink Partners LLC |
Good morning. My name is Shiri and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics' Fourth Quarter and Full Year 2019 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request.